DK1064014T3 - Drug for the prevention or treatment of papilloma virus-specific tumor - Google Patents

Drug for the prevention or treatment of papilloma virus-specific tumor

Info

Publication number
DK1064014T3
DK1064014T3 DK99916884T DK99916884T DK1064014T3 DK 1064014 T3 DK1064014 T3 DK 1064014T3 DK 99916884 T DK99916884 T DK 99916884T DK 99916884 T DK99916884 T DK 99916884T DK 1064014 T3 DK1064014 T3 DK 1064014T3
Authority
DK
Denmark
Prior art keywords
drug
prevention
treatment
papilloma virus
specific tumor
Prior art date
Application number
DK99916884T
Other languages
Danish (da)
Inventor
Alexander Burger
Michael Hallek
Original Assignee
Medigene Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medigene Ag filed Critical Medigene Ag
Application granted granted Critical
Publication of DK1064014T3 publication Critical patent/DK1064014T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK99916884T 1998-03-24 1999-03-24 Drug for the prevention or treatment of papilloma virus-specific tumor DK1064014T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19812941A DE19812941A1 (en) 1998-03-24 1998-03-24 Medicines to prevent or treat papilloma virus-specific tumor
PCT/EP1999/001996 WO1999048518A2 (en) 1998-03-24 1999-03-24 Medicament for preventing or treating papilloma virus-specific tumors

Publications (1)

Publication Number Publication Date
DK1064014T3 true DK1064014T3 (en) 2005-05-30

Family

ID=7862148

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99916884T DK1064014T3 (en) 1998-03-24 1999-03-24 Drug for the prevention or treatment of papilloma virus-specific tumor

Country Status (12)

Country Link
EP (1) EP1064014B1 (en)
JP (1) JP2002509863A (en)
AR (1) AR014768A1 (en)
AT (1) ATE288279T1 (en)
AU (1) AU755242B2 (en)
CA (1) CA2323573A1 (en)
DE (2) DE19812941A1 (en)
DK (1) DK1064014T3 (en)
ES (1) ES2237913T3 (en)
MX (1) MXPA00009282A (en)
PT (1) PT1064014E (en)
WO (1) WO1999048518A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE514982C2 (en) * 1999-09-30 2001-05-28 Active Biotech Ab Carrier containing a major capsid protein L1 from human papillomavirus and its use
DE10059630A1 (en) * 2000-12-01 2002-06-06 Medigene Ag Medicines to prevent or treat tumor caused by human papillomavirus type 18
JP4614765B2 (en) † 2002-05-17 2011-01-19 ユニバーシティ・オブ・ケープ・タウン Chimeric human papillomavirus 16L1 protein containing L2 peptide, virus-like particle prepared therefrom and method for preparing the particle
JP5186678B2 (en) * 2005-10-13 2013-04-17 財団法人ヒューマンサイエンス振興財団 Antigen kit for transdermal antigen administration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435907C2 (en) * 1994-10-07 1997-07-24 Lutz Prof Dr Gissmann Papilloma virus-like particles and their application

Also Published As

Publication number Publication date
AU3521499A (en) 1999-10-18
PT1064014E (en) 2005-06-30
CA2323573A1 (en) 1999-09-30
DE19812941A1 (en) 1999-10-07
DE59911556D1 (en) 2005-03-10
JP2002509863A (en) 2002-04-02
ES2237913T3 (en) 2005-08-01
WO1999048518A2 (en) 1999-09-30
EP1064014B1 (en) 2005-02-02
MXPA00009282A (en) 2002-12-13
ATE288279T1 (en) 2005-02-15
EP1064014A2 (en) 2001-01-03
WO1999048518A3 (en) 1999-12-02
AU755242B2 (en) 2002-12-05
AR014768A1 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
DK1093370T3 (en) Pharmaceutical preparation for the treatment of diabetes
DK1427437T3 (en) OXYNTOMODULIN FOR THE PREVENTION OR TREATMENT OF OVERWEIGHT
DK1147083T3 (en) Arylpiperazinyl-cyclohexylindole derivatives for the treatment of depression
ATE231683T1 (en) MAT FOR THE RELEASE OF VOLATILE SUBSTANCES
DK1123284T3 (en) Process for the preparation of citalopram
DE60019556D1 (en) 2-AMINO-BENZOXAZINE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
DK1173431T3 (en) Process for the preparation of citalopram
DK1021194T3 (en) New improved formulation for the treatment of osteoporosis
DK1105382T3 (en) Process for the preparation of citalopram
DK1032566T3 (en) Process for the preparation of citalopram
DK1159274T3 (en) Process for the preparation of citalopram
DK1063990T3 (en) Use of Biochanine-Enriched Extract for the Treatment of Estrogen-Associated Disorders
DE50015405D1 (en) Grid for the absorption of X-rays
DE60019555D1 (en) 2-OXY-BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
NO20022087D0 (en) Procedure for the treatment of diabetes
DE60030554T8 (en) USES OF ET743 FOR THE TREATMENT OF CANCER
DK1041985T3 (en) Combination of benzocycloheptapyridine compounds and antineoplastic drugs for the treatment of prophylactic disorders
ATE347372T1 (en) VACCINES FOR THE TREATMENT OF MYCOSIS
DE60006412D1 (en) OXAZINOCHINOLONE FOR THE TREATMENT OF VIRAL INFECTIONS
DK1064014T3 (en) Drug for the prevention or treatment of papilloma virus-specific tumor
ITMI991331A0 (en) PROCEDURE FOR THE POLYMERIZATION OF POLYALKYPIPERIDIN
DK1298124T3 (en) Process for the preparation of citalopram
NO983784D0 (en) Processes for the preparation of biphenyl-isoxazole sulfonamides
DK1225890T3 (en) Rivastigmine for the treatment of eye diseases
DE50011084D1 (en) USE OF AZENES FOR THE PREVENTION OF RADIUS-INDUCED SKIN CANCER